📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Rerouting DOT1L inhibitors in leukemia. (2020)

First Author: Dickins RA

Attributed to: Peta-5: A National Facility for Petascale Data Intensive Computation and Analytics funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2020007352

PubMed Identifier: 33091135

Publication URI: http://europepmc.org/abstract/MED/33091135

Type: Journal Article/Review

Volume: 136

Parent Publication: Blood

Issue: 17

ISSN: 0006-4971